Zosuquidar trihydrochloride

Pricing Availability   Qty
Description: High affinity P-gp inhibitor
Alternative Names: LY 335979
Chemical Name: (αR)-4-[(1aα,6α,10bα)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-1-piperazineethanol trihydrochloride
Purity: ≥97% (HPLC)
Datasheet
Citations (3)
Reviews
Literature (1)

Biological Activity for Zosuquidar trihydrochloride

Zosuquidar trihydrochloride is a high affinity P-glycoprotein (P-gp) inhibitor (Kd = 79 nM). Restores doxorubicin (Cat. No. 2252) sensitivity in P-gp-expressing multidrug (MDR) resistant cancer cell lines. Also potentiates antitumor efficacy of taxol (Cat. No. 1097) in a MDR human non-small cell lung carcinoma xenograft mouse model.

Compound Libraries for Zosuquidar trihydrochloride

Zosuquidar trihydrochloride is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.

Technical Data for Zosuquidar trihydrochloride

M. Wt 636.99
Formula C32H31F2N3O2.3HCl
Storage Store at -20°C
Purity ≥97% (HPLC)
CAS Number 167465-36-3
PubChem ID 153997
InChI Key ZPFVQKPWGDRLHL-ZLYBXYBFSA-N
Smiles F[C@@]2(F)[C@H]1C3=C(C=CC=C3)[C@H](N5CCN(C[C@H](COC6=CC=CC7=C6C=CC=N7)O)CC5)C4=C(C=CC=C4)[C@H]12.Cl.Cl.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for Zosuquidar trihydrochloride

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 31.85 50

Preparing Stock Solutions for Zosuquidar trihydrochloride

The following data is based on the product molecular weight 636.99. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.5 mM 3.14 mL 15.7 mL 31.4 mL
2.5 mM 0.63 mL 3.14 mL 6.28 mL
5 mM 0.31 mL 1.57 mL 3.14 mL
25 mM 0.06 mL 0.31 mL 0.63 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets for Zosuquidar trihydrochloride

References for Zosuquidar trihydrochloride

References are publications that support the biological activity of the product.

Dantzig et al (1999) Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities. J.Pharmacol.Exp.Ther. 290 854 PMID: 10411602

Dantzig et al (1996) Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res. 56 4171 PMID: 8797588


If you know of a relevant reference for Zosuquidar trihydrochloride, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Multidrug Transporter Inhibitors

Keywords: Zosuquidar trihydrochloride, Zosuquidar trihydrochloride supplier, LY335979, RS33295198, high, affinity, p-glycoprotein, p-gp, inhibitors, inhibits, multidrug, transporters, resistance, LY, 335979, Multidrug, Transporters, 5456, Tocris Bioscience

3 Citations for Zosuquidar trihydrochloride

Citations are publications that use Tocris products. Selected citations for Zosuquidar trihydrochloride include:

Troy et al (2021) A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity. JCI Insight 6 PMID: 33476303

Dalia et al (2022) Combinatorial Anticancer Drug Screen Identifies Off-Target Effects of Epigenetic Chemical Probes. ACS Chem Biol 17 2801-2816 PMID: 36084291

Terrance G et al (2019) Lower Tubulin Expression in Glioblastoma Stem Cells Attenuates Efficacy of Microtubule-Targeting Agents. ACS Pharmacol Transl Sci 2 402-413 PMID: 32259073


Do you know of a great paper that uses Zosuquidar trihydrochloride from Tocris? Please let us know.

Reviews for Zosuquidar trihydrochloride

There are currently no reviews for this product. Be the first to review Zosuquidar trihydrochloride and earn rewards!

Have you used Zosuquidar trihydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Programmed Cell Death Poster

Programmed Cell Death Poster

There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.